Mark Griffiths

2.8k total citations
14 papers, 218 citations indexed

About

Mark Griffiths is a scholar working on Infectious Diseases, Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Griffiths has authored 14 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Health and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Griffiths's work include Vaccine Coverage and Hesitancy (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Ethics and Legal Issues in Pediatric Healthcare (3 papers). Mark Griffiths is often cited by papers focused on Vaccine Coverage and Hesitancy (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Ethics and Legal Issues in Pediatric Healthcare (3 papers). Mark Griffiths collaborates with scholars based in United States, Canada and Israel. Mark Griffiths's co-authors include Eileen J. Klein, Ahmed Mater, Ran D. Goldman, Renana Gelernter, Samina Ali, Julie C. Brown, Graham C. Thompson, Jeanine E. Hall, Sara Ahmed and Sergio Manzano and has published in prestigious journals such as Blood, Clinical Infectious Diseases and International Journal of Environmental Research and Public Health.

In The Last Decade

Mark Griffiths

11 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Griffiths United States	7	159	128	62	33	28	14	218
Jeanine E. Hall United States	7	153 1.0×	118 0.9×	55 0.9×	31 0.9×	28 1.0×	16	216
Renana Gelernter Israel	8	159 1.0×	119 0.9×	62 1.0×	35 1.1×	28 1.0×	15	243
Julia Hoeffe Canada	9	98 0.6×	78 0.6×	35 0.6×	32 1.0×	21 0.8×	12	247
Achal Bhatt United States	5	207 1.3×	121 0.9×	40 0.6×	25 0.8×	43 1.5×	12	275
Sharon Reece United States	11	236 1.5×	99 0.8×	49 0.8×	29 0.9×	43 1.5×	25	317
Sara Ahmed Canada	5	89 0.6×	77 0.6×	34 0.5×	14 0.4×	19 0.7×	8	144
Mandisa Singata‐Madliki South Africa	10	61 0.4×	95 0.7×	87 1.4×	91 2.8×	29 1.0×	38	294
Solomon Shitu Ethiopia	10	152 1.0×	111 0.9×	52 0.8×	88 2.7×	63 2.3×	17	300
Helen Skirrow United Kingdom	9	220 1.4×	53 0.4×	171 2.8×	92 2.8×	38 1.4×	23	320
Walter Faig United States	6	218 1.4×	140 1.1×	19 0.3×	15 0.5×	75 2.7×	28	309

Countries citing papers authored by Mark Griffiths

Since Specialization

Citations

This map shows the geographic impact of Mark Griffiths's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Griffiths with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Griffiths more than expected).

Fields of papers citing papers by Mark Griffiths

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Griffiths. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Griffiths. The network helps show where Mark Griffiths may publish in the future.

Co-authorship network of co-authors of Mark Griffiths

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Griffiths. A scholar is included among the top collaborators of Mark Griffiths based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Griffiths. Mark Griffiths is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Griffiths, Mark, Patrick S. Sullivan, Grace Mantus, et al.. (2024). Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study. International Journal of Infectious Diseases. 144. 107064–107064.

Brown, Lou Ann S., Frank Harris, Christopher J. Rees, et al.. (2023). Mechanism(s)-of-Action for Arginine Therapy in Children with Sickle Cell Disease and Vaso-Occlusive Pain: Results of a Pharmacokinetics/Pharmacodynamics Study. Blood. 142(Supplement 1). 3861–3861.

Westbrook, Adrianna, Jennifer K. Frediani, Mark Griffiths, et al.. (2022). Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant. Clinical Infectious Diseases. 75(7). 1131–1139. 3 indexed citations

Morris, Claudia R., Nitya Bakshi, Scott Gillespie, et al.. (2022). Impact of Arginine Therapy on Clinical Outcomes, Mitochondrial Function and Oxidative Stress in Children with Sickle Cell Disease Hospitalized with Vasoocclusive Pain Episodes: A Randomized Controlled Trial. Blood. 140(Supplement 1). 16–18. 1 indexed citations

Gutman, Colleen K., Martha Wetzel, Janet Figueroa, et al.. (2022). Comparison of Targeted and Routine Adolescent HIV Screening in a Pediatric Emergency Department. Pediatric Emergency Care. 38(10). e1613–e1619. 2 indexed citations

Davis, Adrienne L., Shashidhar Marneni, Michelle Seiler, et al.. (2021). Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study. Canadian Journal of Emergency Medicine. 23(6). 778–786. 31 indexed citations

Davis, Adrienne L., Shashidhar Marneni, Michelle Seiler, et al.. (2021). 29 Caregiver-Reported Delay in Presentation to Pediatric Emergency Departments for Fear of Contracting COVID-19: A multinational cross-sectional study. Paediatrics & Child Health. 26(Supplement_1). e21–e23.

Goldman, Ran D., Jeffrey N. Bone, Renana Gelernter, et al.. (2021). Willingness to Accept Expedited COVID-19 Vaccine Research for Children Aged <12 Years After Adult Vaccine Approval. Clinical Therapeutics. 44(1). e1–e10. 7 indexed citations

Goldman, Ran D., Samina Ali, Ahmed Mater, et al.. (2021). Caregiver Willingness to Vaccinate Their Children against COVID-19 after Adult Vaccine Approval. International Journal of Environmental Research and Public Health. 18(19). 10224–10224. 44 indexed citations

10.

Goldman, Ran D., Shashidhar Marneni, Tomohiro Katsuta, et al.. (2021). Willingness to Vaccinate Children against Influenza after the Coronavirus Disease 2019 Pandemic. Archive ouverte UNIGE (University of Geneva). 16 indexed citations

11.

Goldman, Ran D., Jeffrey N. Bone, Renana Gelernter, et al.. (2021). National COVID-19 vaccine program progress and parents’ willingness to vaccinate their children. Human Vaccines & Immunotherapeutics. 17(12). 4889–4895. 19 indexed citations

12.

Goldman, Ran D., Shashidhar Marneni, Michelle Seiler, et al.. (2020). Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey. Clinical Therapeutics. 42(11). 2124–2133. 51 indexed citations

13.

Goldman, Ran D., Georg Staubli, Cristina Parra Cotanda, et al.. (2020). Factors associated with parents’ willingness to enroll their children in trials for COVID-19 vaccination. Human Vaccines & Immunotherapeutics. 17(6). 1607–1611. 39 indexed citations

14.

Gutman, Colleen K., Martha Wetzel, Janet Figueroa, et al.. (2020). Unique Needs for the Implementation of Emergency Department Human Immunodeficiency Virus Screening in Adolescents. Academic Emergency Medicine. 27(10). 984–994. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact